Dexamethasone / neomycin / polymyxin B Ophthalmic Ointment
RxNorm 374699
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 374699 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dexamethasone / neomycin / polymyxin B Ophthalmic Ointment.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDFPrescribable
Semantic Clinical Drug Form (SCDF):
Dexamethasone / neomycin / polymyxin B Ophthalmic Ointment
(Atom ID: 12257799)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
DexAMETHasone / neomycin / polymyxin B Ophthalmic Ointment
(Atom ID: 12814396)
Patient Education
Dexamethasone Ophthalmic
Dexamethasone reduces the irritation, redness, burning, and swelling of eye caused by chemicals, heat, radiation, infection, allergy, or foreign bodies in the eye. It is sometimes used after eye surgery.
[Learn More]
Neomycin, Polymyxin, and Bacitracin Ophthalmic
Neomycin, polymyxin, and bacitracin ophthalmic combination is used to treat eye and eyelid infections. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria infecting a surface of the eye.
[Learn More]
* Please review the disclaimer below.